Schedule 13G ownership disclosure

X4 PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98420X103

Event date: 2019-11-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-309318
Form type
SC 13G
Filer
Bain Capital Life Sciences Fund, L.P.
CIK
CIK 1687968
Filed
Dec 09, 2019
Reporting period
Nov 29, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub